The research team RPQure Neuromedical Genetics recently moved from the Netherlands Institute for Neuroscience (NIN) to the Leiden University Medical Center (LUMC) Department of Ophthalmology. Future clinical gene therapy studies for Retinitis Pigmentosa (RP) and Leber congenital amaurosis (LCA) patients with mutations in the CRB1 gene will be performed at the LUMC Department of Ophthalmology in the Netherlands.